Skip to Content

Alphatec Holdings Inc ATEC

Morningstar Rating
$13.42 −0.01 (0.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATEC is trading at a 34% discount.
Price
$13.34
Fair Value
$61.82
Uncertainty
Extreme
1-Star Price
$55.21
5-Star Price
$7.35
Economic Moat
Txnz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATEC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$13.43
Day Range
$13.1013.64
52-Week Range
$8.6619.14
Bid/Ask
$12.52 / $13.40
Market Cap
$1.83 Bil
Volume/Avg
2.2 Mil / 1.7 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.37
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
839

Comparables

Valuation

Metric
ATEC
LUNG
OBIO
Price/Earnings (Normalized)
Price/Book Value
23.923.033.08
Price/Sales
3.375.14
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ATEC
LUNG
OBIO
Quick Ratio
1.865.625.07
Current Ratio
2.866.505.13
Interest Coverage
−10.23−19.37−28.40
Quick Ratio
ATEC
LUNG
OBIO

Profitability

Metric
ATEC
LUNG
OBIO
Return on Assets (Normalized)
−9.88%−22.61%−39.10%
Return on Equity (Normalized)
−31.80%
Return on Invested Capital (Normalized)
−9.93%−25.75%
Return on Assets
ATEC
LUNG
OBIO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesXnnvkj$205.8 Bil
SYK
Stryker CorpDjm$134.3 Bil
MDT
Medtronic PLCNdrh$111.0 Bil
BSX
Boston Scientific CorpQwkkzv$98.5 Bil
EW
Edwards Lifesciences CorpXtfxbv$51.2 Bil
DXCM
DexCom IncQzn$46.9 Bil
ZBH
Zimmer Biomet Holdings IncDzxg$25.4 Bil
ALGN
Align Technology IncSswtvy$23.0 Bil
PHG
Koninklijke Philips NV ADRXmhgtdc$18.4 Bil
PODD
Insulet CorpHzqxb$11.8 Bil

Sponsor Center